Article Text

FRI0289 Multicenter Registry on Inflammatory Myopathies in Madrid (REMICAM): Mortality Analysis
  1. L. Nuño1,
  2. M.J. García2,
  3. B. Joven3,
  4. V. Maldonado4,
  5. I. Llorente5,
  6. C. Barbadillo6,
  7. P. García de la Peña7,
  8. L. Ruiz8,
  9. H. Moruno9,
  10. T. Cobo10,
  11. R. Almodovar11,
  12. L. Lojo12,
  13. F.J. Lόpez Longo13,
  14. on behalf of REMICAM Study Group
  1. 1H.La Paz
  2. 2Instituto de Salud Musculoesquelética
  3. 3H.Doce de Octubre
  4. 4H.Ramόn y Cajal
  5. 5H.La Princesa
  6. 6H.Puerta de Hierro
  7. 7H.Madrid Norte Sanchinarro
  8. 8H.Niño Jesús, Madrid
  9. 9H.Príncipe de Asturias, Alcalá de Henares
  10. 10H.Infanta Sofía, San Sebastián de los Reyes
  11. 11H.F.Alcorcόn, Alcorcόn
  12. 12H.Infanta Leonor
  13. 13H.Gregorio Marañόn, Madrid, Spain


Background Classically the prognosis of idiopathic inflammatory myopathies (IIM) has improved in recent decades, but can still be poor in certain subgroups or in the presence of some clinical factors.

Objectives To analyze survival, causes of death and poor prognosis factors in a cohort of patients diagnosed with IIM.

Methods A multicenter retrospective study from REMICAM1 myositis study group was performed. All patients were diagnosed with IIM according to Bohan and Peter2 criteria and were classified into 5 different clinical subgroups: primary dermatomyositis (DM), primary polymyositis (PM), juvenile dermatomyositis (JuvM), cancer associated myositis (CAM) and overlap myositis (OM).

Results 478 IIM cases were included. 74% of the cases were women, with an age at diagnosis of 43.7±22.6 ys. and a mean follow-up of 9.7±8.3 ys. During the follow-up period there were a total of 114 deaths (24%), the main causes were infections (24%), cancer (24%), and cardiovascular events (22%). Factors associated with poor prognosis were CAM (HR 15.4) and OM subgroups (HR 4.55), older age at diagnosis (HR 1.05), shorter time of disease (HR 1.30), serious infections (HR 4.57), cancer (HR 3.07), systemic symptoms (HR 1.64), heart (HR 2.52) and haematological manifestations (HR 1.53), ESR/CRP elevation at baseline (HR 3.05) and chronic renal failure (HR 2.41). The clinical characteristics that showed a protective effect were arthralgia (HR 0.68), typical skin lesions (HR 0.62), drug use (HR 0.53) and female sex (HR 0.5). In multivariate analysis the independent variables associated with mortality were CAM (HR 8.83) and OM (HR 5.17) subgroups, severe infections (HR 3.42), older age at diagnosis (HR 1.03), shorter course of the disease (HR 1.34), thrombocytopenia (HR 2.93) and elevated ESR/CRP (HR 2.47).

Conclusions In our REMICAM registry on inflammatory myopathies 24% of patients died, mainly due to infections, cancer and cardiovascular events. The independent predictors of mortality were belonging to the subgroups of paraneoplastic myopathies or overlap syndrome, the presence of severe infections, thrombocytopenia, elevated ESR/CRP at baseline, shorter course of the disease and older age at onset.

  1. REMICAM: Registry on inflammatory myopathies in Madrid

  2. Bohan A, Peter JB. N Engl J Med 1975 Feb 13;292(7):344–7.

Disclosure of Interest L. Nuño Grant/research support from: SORCOM-MSD grant for myositis study, M. J. García: None declared, B. Joven: None declared, V. Maldonado: None declared, I. Llorente: None declared, C. Barbadillo: None declared, P. García de la Peña: None declared, L. Ruiz: None declared, H. Moruno: None declared, T. Cobo: None declared, R. Almodovar: None declared, L. Lojo: None declared, F. J. Lόpez Longo: None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.